A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia

OBJECTIVES: Benign prostatic hyperplasia (BPH) is a common and progressive disease affecting elderly males, often associated with lower urinary tract symptoms (LUTS). α1-blockers are the mainstay in symptomatic therapy of BPH. Because of their greater uroselectivity and minimal hemodynamic effects,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Indian J Pharmacol
Autors principals: Manjunatha, R., Pundarikaksha, H. P., Madhusudhana, H. R., Amarkumar, J., Hanumantharaju, B. K.
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications & Media Pvt Ltd 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4825428/
https://ncbi.nlm.nih.gov/pubmed/27127315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.178825
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars